A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients

被引:2
作者
Dutta, Roop [1 ]
Ryan, John G. [1 ]
Hurley, Sally [1 ]
Wylie, John [1 ,2 ]
机构
[1] St Elizabeths Med Ctr, Boston, MA USA
[2] Pfizer Inc, New York, NY USA
来源
HEART RHYTHM O2 | 2024年 / 5卷 / 05期
关键词
Atrial fibrillation; Educational intervention; Oral anticoagulation; Population health; Primary care; Quality improvement; CARE;
D O I
10.1016/j.hroo.2024.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Anticoagulation is the cornerstone of atrial fibrillation (AF) management for stroke prevention. Recently, we showed that oral anticoagulation (OAC) rates of AF patients in a large U.S. multispecialty health system are >80%. Objective The purpose of this study was to improve OAC rates in AF patients via an educational intervention targeted to primary care providers with low OAC rates. Methods Primary care clinicians were stratified by proportions of their AF patients at elevated stroke risk not taking anticoagulation medication. Clinicians with the lowest rates of anticoagulation were assigned to a target group receiving an educational program consisting of E-mail messaging summarizing anticoagulation guidelines. All other clinicians were assigned to a comparison group (CG). Data from a 6-month lead-in phase were compared with a 6-month follow-up period to determine whether the proportion of AF patients treated with OACs had changed. Results Of the 141 primary care clinicians with patients who met the inclusion criteria, 36 (25.53%) were assigned to the educational group (EG) and 105 (74.47%) to the CG. At baseline, there was a significant difference in percent of high-risk AF patients who were untreated in the EG (20.65%) compared to the high-risk patients who were untreated in the CG (13.64%; P = .001). After the educational intervention, high-risk AF patients without anticoagulation decreased in both EG (15.47%; P = .047) and CG (10.14%; P = .07), with greater absolute reduction in the EG (5.19% vs 3.50%). Conclusion A targeted education program was associated with increased anticoagulation rates for AF patients at high risk for stroke.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 50 条
  • [31] Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
    Beyer-Westendorf, Jan
    Ehlken, Birgit
    Evers, Thomas
    EUROPACE, 2016, 18 (08): : 1150 - 1157
  • [32] Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
    Amin, Alpesh
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 75 - 84
  • [33] Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update
    Chen, Shaojie
    Chun, K. R. Julian
    Ling, Zhiyu
    Liu, Shaowen
    Zhu, Lin
    Wang, Jiazhi
    Schratter, Alexandra
    Acou, Willem-Jan
    Kiuchi, Marcio Galindo
    Yin, Yuehui
    Schmidt, Boris
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (06)
  • [34] Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
    Gallego, Pilar
    Roldan, Vanessa
    Marin, Francisco
    Romera, Marta
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1189 - 1198
  • [35] Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
    Rivera-Caravaca, Jose Miguel
    Roldan, Vanessa
    Asuncion Esteve-Pastor, Maria
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    Marin, Francisco
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (07) : 1448 - 1454
  • [36] Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure
    Prochaska, Juergen H.
    Goebel, Sebastian
    Nagler, Markus
    Knoepfler, Torben
    Eggebrecht, Lisa
    Lamparter, Heidrun
    Panova-Noeva, Marina
    Keller, Karsten
    Coldewey, Meike
    Bickel, Christoph
    Lauterbach, Michael
    Hardt, Roland
    Espinola-Klein, Christine
    ten Cate, Hugo
    Rostock, Thomas
    Muenzel, Thomas
    Wild, Philipp S.
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (12) : 1170 - 1179
  • [38] Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding
    Mascarenhas, Daniel A. N.
    Farooq, Mohammad U.
    Ziegler, Paul D.
    Kantharia, Bharat K.
    EUROPACE, 2016, 18 (06): : 799 - 806
  • [39] Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk
    Chao, Tze-Fan
    Chan, Yi-Hsin
    Chiang, Chern-En
    Tuan, Ta-Chuan
    Liao, Jo-Nan
    Chen, Tzeng-Ji
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (07) : 730 - 738
  • [40] Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
    Sanchez-Gonzalez, Carmen
    Herrero Calvo, Jose Antonio
    NEFROLOGIA, 2022, 42 (06): : 632 - 644